Cancer Biomarkers - Global Strategic Business Report

Global Cancer Biomarkers Market to Reach $68.9 Billion by 2030

The global market for Cancer Biomarkers estimated at US$20.2 Billion in the year 2022, is projected to reach a revised size of US$68.9 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2022-2030. Protein Biomarkers, one of the segments analyzed in the report, is projected to record 17.3% CAGR and reach US$42.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Genetic Biomarkers segment is readjusted to a revised 16% CAGR for the next 8-year period.

The U.S. Market is Estimated at $5.5 Billion, While China is Forecast to Grow at 23.4% CAGR

The Cancer Biomarkers market in the U.S. is estimated at US$5.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$18.3 Billion by the year 2030 trailing a CAGR of 23.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 13.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.4% CAGR.

Select Competitors (Total 33 Featured) -

• Abbott Laboratories
• Agilent Technologiesent
• Becton, Dickinson and Company
• Biomérieux Sant
• Bio-Rad Laboratories
• Danaher Corporation
• GE Healthcare
• Hologic
• Illuminat
• Merck & Co.
• Myriad Genetics
• Qiagen N.V.
• Quest Diagnostics
• Roche Diagnostics
• Sysmex Corporation
• Thermo Fisher Scientific

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year